Brookstone Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.28M Sell
52,678
-2,628
-5% -$64K 0.02% 506
2025
Q1
$1.15M Sell
55,306
-3,161
-5% -$65.6K 0.02% 524
2024
Q4
$1.38M Sell
58,467
-8,017
-12% -$189K 0.02% 445
2024
Q3
$1.7M Sell
66,484
-5,954
-8% -$152K 0.03% 404
2024
Q2
$1.94M Sell
72,438
-8,254
-10% -$221K 0.03% 374
2024
Q1
$2.32M Buy
80,692
+1,959
+2% +$56.3K 0.04% 336
2023
Q4
$2.58M Sell
78,733
-11,624
-13% -$381K 0.05% 293
2023
Q3
$2.16M Sell
90,357
-9,628
-10% -$230K 0.05% 291
2023
Q2
$3.31M Sell
99,985
-4,483
-4% -$149K 0.07% 246
2023
Q1
$3.21M Sell
104,468
-3,711
-3% -$114K 0.06% 249
2022
Q4
$3.06M Sell
108,179
-40,792
-27% -$1.15M 0.06% 236
2022
Q3
$4.76M Sell
148,971
-22,002
-13% -$702K 0.11% 172
2022
Q2
$6.41M Buy
170,973
+6,698
+4% +$251K 0.14% 149
2022
Q1
$7.01M Sell
164,275
-19,750
-11% -$843K 0.14% 150
2021
Q4
$9.98M Sell
184,025
-14,807
-7% -$803K 0.17% 118
2021
Q3
$14.6M Sell
198,832
-8,514
-4% -$627K 0.26% 81
2021
Q2
$17.9M Buy
207,346
+5,957
+3% +$515K 0.32% 79
2021
Q1
$17.9M Buy
201,389
+47,053
+30% +$4.17M 0.68% 39
2020
Q4
$14.4M Buy
154,336
+45,628
+42% +$4.26M 0.57% 37
2020
Q3
$6.93M Buy
108,708
+48,098
+79% +$3.06M 0.32% 55
2020
Q2
$3.16M Buy
60,610
+33,698
+125% +$1.76M 0.2% 76
2020
Q1
$842K Buy
26,912
+9,331
+53% +$292K 0.05% 174
2019
Q4
$589K Buy
17,581
+7,387
+72% +$247K 0.03% 258
2019
Q3
$301K Buy
+10,194
New +$301K 0.02% 341
2018
Q4
Sell
-27,504
Closed -$919K 309
2018
Q3
$919K Buy
+27,504
New +$919K 0.07% 184